logo
London Marathon: The Sussex runners taking on the 26.2 mile course

London Marathon: The Sussex runners taking on the 26.2 mile course

BBC News25-04-2025
Three determined Sussex runners have shared their different reasons for taking part in the London Marathon.More than 56,000 people are expected to take on the 26.2 mile (42.2 km) course on Sunday.The route passes Cutty Sark and Canary Wharf before finishing on The Mall, close to Buckingham Palace.Becki Malloy, Bethany Wood and Jon Carter explain what motivates them to take on the challenge.
Becki Malloy
Becki Malloy, from Horsham, will be running the London Marathon for the National Brain Appeal. Her father was diagnosed with early onset Alzheimer's at the age of 52 and she carries the same gene, which means she is very likely to develop the disease at a similar age.She said: "Running the London Marathon was on my bucket list so I took the crazy leap to do it."It was devastating when I found out what had happened to my dad but at the time I was quite naive, I thought it was an older person's disease."He couldn't remember me but he was still there."He father passed way last year.
Ms Malloy says she hopes the money raised will help University College London to find a cure and support people when a diagnosis is given.She has previously completed half marathons but said the training has been "a lot harder" than she thought it would be."I've chafed in places I never thought I would," she said. Ms Malloy said the training takes over "everything", adding: "I can't say I'll be running another one too soon afterwards."
Bethany Wood
Bethany Wood decided to run for the Cystic Fibrosis Trust as she has the condition. Cystic fibrosis is a genetic condition, causing the body's organs fill up with mucus, often with the lungs being affected the most. She wants to show people with cystic fibrosis that "life can go on and you can still go and do amazing things".Ms Wood said: "It also affects your pancreas, so a large number of people with cystic fibrosis also have diabetes as they don't have insulin like the standard person."
The London Marathon will be Ms Wood's 10th marathon in just 10 weeks.The mother-of-two says it is part of a big legacy challenge she is undertaking."I think my body will be screaming at me by the London Marathon," she said."I can't wait to finish and get home and take my shoes off and have a glass of wine for the first time in 10 months. I also can't wait to run a 5k in my local park."This is her second London Marathon.The first time she completed it, she gave the medal to her eldest daughter.She says she will be giving this medal to her other daughter.
Jon Carter
Jon Carter is running to support his son, Ethan, who has arthrogryposis multiplex congenita (AMC), a rare congenital condition affecting joint mobility.He said the charity he is supporting - Whizz Kidz - has changed his family's life.He said: "My son has been a in a wheelchair since he was born. "He is an absolutely amazing character and so persevering, but I want to show him through hard work you can achieve more than you expect."The charity has provided his son with an electric wheelchair, which he is able to control himself, meaning he does not people to push him around anymore.
Mr Carter admitted that he "doesn't like running".He said: "I'm really pushing myself to do this."Audio books have helped me a lot through my long runs in training. "It's been hard work. I'll probably collapse when I have finished but we have planned to have a fish and chip dinner as a treat when we get home."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Elon Musk's brain chips to be tested on Britons in new clinical trial
Elon Musk's brain chips to be tested on Britons in new clinical trial

Daily Mail​

time11 hours ago

  • Daily Mail​

Elon Musk's brain chips to be tested on Britons in new clinical trial

British patients are set to receive Elon Musk's Neuralink brain chips as part of the first UK clinical trial. Neuralink is partnering with University College London Hospitals Trust and Newcastle Hospitals for the project, the company said in an announcement. Seven participants who cannot walk will be fitted with an implant about the size of a 10p coin, allowing them to control a smartphone with their mind. Those living with paralysis due to conditions such as spinal cord injuries and a nervous system disease called amyotrophic lateral sclerosis qualify for the study, the company revealed in a post on X. This comes after a paralysed woman in the US revealed the shocking effect the brain implant has already had on her life. Audrey Crews, who has been paralysed since she was 16, became one of five people in the US who have already been implanted with the brain chip. Speaking on X, Ms Crews revealed how she was now able to write her signature for the first time since losing the use of her legs and arms in a car accident. Ms Crews said: 'I tried writing my name for the first time in 20 years. I'm working on it.' Neuralink's N1 Chip, known as a brain-computer-interface (BCI), is a small implant which links the human brain to a computer through 128 threads thinner than a human hair. Each thread contains eight electrodes, which are inserted into the surface of the brain to read spikes in electrical activity. Those signals are recorded and sent to a computer, which converts them into commands for common devices such as moving a cursor or clicking. According to Neuralink, the chip can 'restore digital autonomy to individuals with severe paralysis by enabling them to control devices with their thoughts'. Participants in the UK trial will have their implants implanted by a surgeon while a robot implants the tiny threads. Professor Harith Akram, a consultant neurosurgeon at University College London and chief investigator for the study, said the trial 'represents a major milestone in the development of brain-computer interface technology, with the potential to transform the lives of people living with severe neurological disorders worldwide.' After resolving safety concerns flagged by the US Food and Drug Administration, Neuralink began US clinical trials in 2023. Noland Arbaugh, 30, a quadriplegic from Arizona, became the first person to receive the Neuralink brain chip. The implant allowed Mr Arbaugh to write, play chess, and even enjoy complicated video games. Although many of the electrodes became disconnected from Mr Arbaugh's brain, Neuralink enabled him to maintain control by improving the software that reads brain signals. Similarly, Ms Crews has shared how receiving the brain implant has restored a level of autonomy she had long considered lost. At the age of 16, Ms Crews was severely injured in a car accident, which damaged the C4 and C5 vertebrae in her neck, leaving her a quadriplegic with no feeling in her arms and legs. However, after being implanted with the N1 chip in July, Ms Crews has shared her renewed ability to use a computer. In her posts on X following the surgery, Crews revealed how she has been able to draw pictures, write words, scroll with a mouse, and use a keyboard all through the power of her mind. Responding to the positive feedback she's received on social media, Crews said she felt liberated, and she's even started taking requests on what to draw next as the pictures act as practice for her while using the implant. 'Imagine your pointer finger is left click and the cursor [movement] is with your wrist, without physically doing it. Just a normal day using telepathy,' she explained while showing off her latest drawings. Mr Musk also replied to a post about Crews' story, saying: 'She is controlling her computer just by thinking. Most people don't realize this is possible.' The first female Neuralink patient noted that the BCI won't give her the ability to walk again or regain any movement in her limbs, but she is hoping this breakthrough will allow her to write a book about her journey. 'I've been a quadriplegic since the age of 16, so I have lots to tell,' Crews explained. Mr Musk, the CEO of SpaceX and Tesla, co-founded Neuralink in 2016 with a group of neuroscience, engineering, and robotics experts. Their goal was to merge human intelligence with artificial intelligence, treat brain disorders and potentially enhance human capabilities.

Father-of-two 'smelled like bleach' before 'dark shadow' was found on his brain
Father-of-two 'smelled like bleach' before 'dark shadow' was found on his brain

Daily Mirror

time11 hours ago

  • Daily Mirror

Father-of-two 'smelled like bleach' before 'dark shadow' was found on his brain

Sam Suriakumar was in his bathroom when the smell of a cleaning agent 'almost filled up (his) mouth' A father-of-two who received a diagnosis of an inoperable brain tumour after noticing the smell of bleach has urged others in similar situations to 'hold on to hope and positivity in whatever way you can'. ‌ Sam Suriakumar, 40, was in his bathroom one day in February 2020 when the unusual scent of a cleaning product 'almost filled up (his) mouth', leaving him feeling lightheaded. Initially assuming his wife Sindhu had recently been cleaning, Sam dismissed the symptom as likely nothing. ‌ But when the keen fitness enthusiast attended his gym session the next day, the peculiar odour and wooziness returned. During his homeward journey, Sam, a Worcester Park resident, suffered a 'massive grand mal seizure' whilst travelling on the London Underground. ‌ Emergency services transported him to the hospital for examination, where medics identified a 'large shadow' on the left side of his brain. He was later diagnosed with a brain tumour on February 4, 2020. "The smell of ammonia, bleach or some sort of cleaning agent was almost filling up my mouth, it was really strong," he said. "I felt like I needed to lean against the wall and use the radiator to stand, I felt very strange." ‌ Looking back on his seizure, Sam then added: "I closed my eyes and it felt like half an hour went by, but we had only moved one stop...I'd seized up so bad that I dislocated my shoulder." Whilst the mass remained stable for around two years, Sam received the heartbreaking news in 2023 that it had grown towards the front of his brain. The tumour's location in areas crucial for speech, memory, and movement renders surgical intervention nearly impossible. ‌ So, Sam instead underwent 30 sessions of radiotherapy and nine months of chemotherapy to try to halt its growth. His tumour is now in a monitoring phase, and Sam will have scans every six months to better understand the impacts of the treatment. On July 26, Sam celebrated his 40th birthday, a milestone he didn't think he would reach. He has tried to turn his situation into 'something positive', aiming to encourage and inspire others. ‌ "I'm trying to use my experience to inspire people and turn this into something positive, rather than letting it define me as this poor guy with a sad story," Sam told PA Real Life. "I want to provide encouragement and inspiration to others, in that we can fight and we don't have to let it define us. "Hold on to hope and positivity in whatever way you can." In 2023, Sam participated in the London Marathon to fundraise for Brain Tumour Research, and through various initiatives, he has raised approximately £60,000 for charity thus far. To further spread awareness, he took on the role of a supporter ambassador for Brain Tumour Research in 2023, which led him to engage in public speaking and recount his personal experiences. For others in his situation, Sam said he would send them a 'massive hug'. "Your brain talks to every single part of your body and it's so important to have a positive mindset," he said. "It's not going to come every single day, but try to find those things that inspire and encourage you to help you move forward."

Britons to receive Elon Musk's brain chips in new clinical trial - as paralysed woman reveals the implant's shocking effects
Britons to receive Elon Musk's brain chips in new clinical trial - as paralysed woman reveals the implant's shocking effects

Daily Mail​

time12 hours ago

  • Daily Mail​

Britons to receive Elon Musk's brain chips in new clinical trial - as paralysed woman reveals the implant's shocking effects

British patients are set to receive Elon Musk 's Neuralink brain chips as part of the first UK clinical trial. Neuralink is partnering with University College London Hospitals Trust and Newcastle Hospitals for the project, the company said in an announcement. Seven participants who cannot walk will be fitted with an implant about the size of a 10p coin, allowing them to control a smartphone with their mind. Those living with paralysis due to conditions such as spinal cord injuries and a nervous system disease called amyotrophic lateral sclerosis qualify for the study, the company revealed in a post on X. This comes after a paralysed woman in the US revealed the shocking effect the brain implant has already had on her life. Audrey Crews, who has been paralysed since she was 16, became one of five people in the US who have already been implanted with the brain chip. Speaking on X, Ms Crews revealed how she was now able to write her signature for the first time since losing the use of her legs and arms in a car accident. Ms Crews said: 'I tried writing my name for the first time in 20 years. I'm working on it.' Neuralink's N1 Chip, known as a brain-computer-interface (BCI), is a small implant which links the human brain to a computer through 128 threads thinner than a human hair. Each thread contains 1,000 electrodes, which are inserted into the surface of the brain to read spikes in electrical activity. Those signals are recorded and sent to a computer, which converts them into commands for common devices such as moving a cursor or clicking. According to Neuralink, the chip can 'restore digital autonomy to individuals with severe paralysis by enabling them to control devices with their thoughts '. Participants in the UK trial will have their implants inserted by a robotic surgeon at London's UCLH National Hospital for Neurology and Neurosurgery. Professor Harith Akram, a consultant neurosurgeon at University College London and chief investigator for the study, said the trial 'represents a major milestone in the development of brain-computer interface technology, with the potential to transform the lives of people living with severe neurological disorders worldwide.' After resolving safety concerns flagged by the US Food and Drug Administration, Neuralink began US clinical trials in 2023. Noland Arbaugh, 30, a quadriplegic from Arizona, became the first person to receive the Neuralink brain chip. The implant allowed Mr Arbaugh to write, play chess, and even enjoy complicated video games. Although many of the electrodes became disconnected from Mr Arbaugh's brain, Neuralink enabled him to maintain control by improving the software that reads brain signals. Similarly, Ms Crews has shared how receiving the brain implant has restored a level of autonomy she had long considered lost. At the age of 16, Ms Crews was severely injured in a car accident, which damaged the C4 and C5 vertebrae in her neck, leaving her a quadriplegic with no feeling in her arms and legs. However, after being implanted with the N1 chip in July, Ms Crews has shared her renewed ability to use a computer. In her posts on X following the surgery, Crews revealed how she has been able to draw pictures, write words, scroll with a mouse, and use a keyboard all through the power of her mind. Responding to the positive feedback she's received on social media, Crews said she felt liberated, and she's even started taking requests on what to draw next as the pictures act as practice for her while using the implant. 'Imagine your pointer finger is left click and the cursor [movement] is with your wrist, without physically doing it. Just a normal day using telepathy,' she explained while showing off her latest drawings. Mr Musk also replied to a post about Crews' story, saying: 'She is controlling her computer just by thinking. Most people don't realize this is possible.' The first female Neuralink patient noted that the BCI won't give her the ability to walk again or regain any movement in her limbs, but she is hoping this breakthrough will allow her to write a book about her journey. 'I've been a quadriplegic since the age of 16, so I have lots to tell,' Crews explained. Mr Musk, the CEO of SpaceX and Tesla, co-founded Neuralink in 2016 with a group of neuroscience, engineering, and robotics experts. Their goal was to merge human intelligence with artificial intelligence, treat brain disorders and potentially enhance human capabilities. The billionaire said in June that the chip technology had made 'an incredible amount of progress'. But he emphasised the company's cautious approach, adding: 'The reason we're not moving faster than we are is because we're taking great care with each individual to make sure we never miss - and, so far, we haven't.' Elon Musk's Neuralink is working to link the human brain with a machine interface by creating micron-sized devices. Neuralink was registered in California as a 'medical research' company in July 2016, and Musk has funded the company mostly by himself. It is working on what Musk calls the 'neural lace' technology, implanting tiny brain electrodes that may one day upload and download thoughts. The technology is initially planned to be used to help people suffering from severe degenerative brain disorders such as ALS, but it could have wider uses in years to come.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store